Evidence map›Paper›PMID 27217203›Full record

ArticleLab on a chip2016

3D-printing of transparent bio-microfluidic devices in PEG-DA.

Arturo Urrios, Cesar Parra-Cabrera, Nirveek Bhattacharjee, Alan M Gonzalez-Suarez, Luis G Rigat-Brugarolas, Umashree Nallapatti, Josep Samitier, Cole A DeForest, Francesc Posas, José L Garcia-Cordero and 1 more

Open access · greenAbstract read
In one paragraph

Article in Lab on a chip, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 102 papers.

0numbers the graph read from it
0cells of the map it votes in
102citing papers in PubMed
14.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

102 citing papers in PubMed, 277 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

42 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 5 countries.

Arturo UrriosCell Signaling Research Group, Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra (UPF), E-08003 Barcelona, Spain.
Cesar Parra-Cabrera
Nirveek Bhattacharjee
Alan M Gonzalez-Suarez
Luis G Rigat-Brugarolas
Umashree Nallapatti
Josep Samitier
Cole A DeForest
Francesc Posas
José L Garcia-Cordero
Albert Folch
Seattle University · USUniversity of Washington · USPompeu Fabra University · ESTecnológico de Monterrey · MXUniversitat de Barcelona · ES

Funding

Microfluidic Device to Profile Chemosensitivity in Glioma Slice CulturesR01CA181445 · NCI · UNIVERSITY OF WASHINGTON · PI FOLCH, ALBERT · 2014 to 2025
$5.3M
Multiplexed Microfluidic Gradients for Axon GuidanceR01NS064387 · NINDS · UNIVERSITY OF WASHINGTON · PI FOLCH, ALBERT · 2011 to 2015
$1.6M
NCI NIH HHS R01 CA181445NINDS NIH HHS R01 NS064387
6 · The paper itself

Abstract

The vast majority of microfluidic systems are molded in poly(dimethylsiloxane) (PDMS) by soft lithography due to the favorable properties of PDMS: biocompatible, elastomeric, transparent, gas-permeable, inexpensive, and copyright-free. However, PDMS molding involves tedious manual labor, which makes PDMS devices prone to assembly failures and difficult to disseminate to research and clinical settings. Furthermore, the fabrication procedures limit the 3D complexity of the devices to layered designs. Stereolithography (SL), a form of 3D-printing, has recently attracted attention as a way to customize the fabrication of biomedical devices due to its automated, assembly-free 3D fabrication, rapidly decreasing costs, and fast-improving resolution and throughput. However, existing SL resins are not biocompatible and patterning transparent resins at high resolution remains difficult. Here we report procedures for the preparation and patterning of a transparent resin based on low-MW poly(ethylene glycol) diacrylate (MW 250) (PEG-DA-250). The 3D-printed devices are highly transparent and cells can be cultured on PEG-DA-250 prints for several days. This biocompatible SL resin and printing process solves some of the main drawbacks of 3D-printed microfluidic devices: biocompatibility and transparency. In addition, it should also enable the production of non-microfluidic biomedical devices.

Indexed as

Lab-On-A-Chip DevicesPrinting, Three-DimensionalAnimalsCell Culture TechniquesCHO CellsCricetulusHippocampusMaterials TestingMiceNeuronsPolyethylene GlycolsUltraviolet Rayspoly(ethylene glycol)diacrylatePolyethylene Glycols

Identifiers

PMID27217203
PMCPMC4930360
OpenAlexW2381249236

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.